Thermo Fisher

RnD Development Engineer - Assay Development

Uppsala, Sweden Full time

Work Schedule

Standard (Mon-Fri)

Environmental Conditions

Laboratory Setting, Office, Some degree of PPE (Personal Protective Equipment) required (safety glasses, gowning, gloves, lab coat, ear plugs etc.)

Job Description

As part of the Thermo Fisher Scientific team, you’ll discover meaningful work that makes a positive impact on a global scale. Join our colleagues in bringing our Mission to life every single day to enable our customers to make the world healthier, cleaner and safer.

Location/Division Specific Information: 

At Olink, or the proteomic sciences division, we are transforming the understanding of human diseases through advanced protein biomarker discovery. With our innovative Olink solutions – including highly specific and validated assays that cover more than 5,000 proteins – our colleagues and technology empower scientists in groundbreaking research that will play a pivotal role in the future of personalized medicine. 


Job Description:

We are seeking a Development Engineer to join the Assay Development NGS team within the Highplex department at RnD on a temporary basis. If you want to work with a leading technology that supports precision medicine you might the person we are looking for.

Assay Development NGS is responsible for developing immunoassays for Olink's Highplex products, such as Olink Explore HT and Olink Reveal and assessing assay performance throughout development projects. This includes performing verification experiments and generating assay performance data for website. Product development is carried out in projects with members from other departments. Furthermore, Assay Development NGS also work with research and development of product concepts and ideas.

The role is based at the Olink HQ in Uppsala and reports to the Assay Development Manager. Please note that this is fixed term position starting in 2026 and extending to the end of June 2027.

Main Responsibilities:

  • Perform experiments using Olinks PEA (Proximity Extension Assay) with NGS as a readout platform.
  • Plan and perform laboratory work in accordance with set project plans and work schedules.
  • Evaluate, report and document results from the laboratory work according to existing procedures.
  • Manage and record data for extensive collections of antibodies, antigens, and biological samples.
  • Contribute to set project plans
  • Actively engage in the development of the group's and department's activities and take part in improvement projects.

Qualifications

  • Master's degree in life sciences or equivalent experience.
  • Solid lab experience, pipetting small volumes (<5μl)
  • Solid understanding of immunoassays
  • Experience working with qPCR or NGS protocols
  • Experience managing substantial quantities of reagents and data.
  • Good computer skills in general and good knowledge of Excel.
  • A few years of working experience from the industry is advantageous.
  • Experience in using pipetting robots is advantageous.
  • Proficient in spoken and written English, Swedish is a plus.

As a person you are responsible, driven, proactive, and oriented toward solutions. Because we process large quantities of reagents and data, being detailed and structured is essential. You are a teammate who easily communicates and works with people within the group and in other departments. It is crucial to have a positive attitude and flexibility, as we focus heavily on serving customers.

Why Join Us? 

At Olink, Thermo Fisher Scientific, you will be part of a nurturing team that values integrity, innovation, and involvement. We offer an encouraging environment where your diverse experiences and perspectives are appreciated, enabling you to thrive and excel in your career. Come aboard and contribute significantly to global health and safety! 

If you believe you’re the right fit for this role, we encourage you to submit your resume along with a cover letter highlighting your relevant experience, we will be reviewing all applications after the final application date, January 7th 2026.